Scintigraphy for Prediction In Rheumatoid Intentional Therapy Tapering

Not yet recruitingOBSERVATIONAL
Enrollment

86

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2025

Conditions
Rheumatoid Arthritis
Interventions
RADIATION

99mMaracticaltide imaging

7.3.1 99mTc-maraciclatide imaging This will be undertaken at baseline and optionally at 8-12 weeks. Not more than 75 µg of 99mTc-maraciclatide will be administered intravenously with an activity as close as possible to 740 MBq. Static whole-body imaging will be undertaken after a maximum of 2 hours with further dedicated views of the hands and feet. Total image acquisition time will be approximately 30 minutes. Images will be scored by quantitative and semi-quantitative methods by a blinded observer.

All Listed Sponsors
collaborator

The Leeds Teaching Hospitals NHS Trust

OTHER

collaborator

Serac Healthcare

UNKNOWN

collaborator

Versus Arthritis

OTHER

lead

Guy's and St Thomas' NHS Foundation Trust

OTHER

NCT05983848 - Scintigraphy for Prediction In Rheumatoid Intentional Therapy Tapering | Biotech Hunter | Biotech Hunter